At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Perichondrium Autograftsprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Autologous Perichondrium Transplantation for Replacement of Stem Cells and Their Niche in the Treatment of Necrotizing Scleritis
Chung-Ang University Hosptial, Chung-Ang University College of Medicine·interventional·Posted Aug 12, 2016·Updated Aug 12, 2016
In Brief
A clinical study evaluating Perichondrium Autografts for Necrotizing Scleritis. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Necrotizing scleritis with severe ischemia is refractory to conventional treatment because of avascular necrosis. The investigators assessed the therapeutic efficacy and safety of autologous perichondrium transplantation in patients with severe ischemic necrotizing scleritis, and analyzed the therapeutic effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNecrotizing Scleritis
CountriesSouth Korea
CollaboratorsMinistry of Science and ICT, Republic of Korea
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2011
Primary CompletionJun 2016
First PostedAug 2016
TodayJul 2026
First PostedAug 12, 2016
Enrollment StartMar 1, 2011
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 9.9 years ago
Interventions
Perichondrium Autograftsprocedure
Perichondrium tissue was harvested from the patient's ear cartilage and transplanted to reconstruct the scleral defect.